BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11795261)

  • 1. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity.
    Konstantinides S; Schafer K; Loskutoff DJ
    Ann N Y Acad Sci; 2001 Dec; 947():134-41; discussion 141-2. PubMed ID: 11795261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity.
    Konstantinides S; Schäfer K; Koschnick S; Loskutoff DJ
    J Clin Invest; 2001 Nov; 108(10):1533-40. PubMed ID: 11714745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity.
    Barouch LA; Gao D; Chen L; Miller KL; Xu W; Phan AC; Kittleson MM; Minhas KM; Berkowitz DE; Wei C; Hare JM
    Circ Res; 2006 Jan; 98(1):119-24. PubMed ID: 16339484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance.
    Bodary PF; Shen Y; Ohman M; Bahrou KL; Vargas FB; Cudney SS; Wickenheiser KJ; Myers MG; Eitzman DT
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):70-6. PubMed ID: 17095713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice.
    Barouch LA; Berkowitz DE; Harrison RW; O'Donnell CP; Hare JM
    Circulation; 2003 Aug; 108(6):754-9. PubMed ID: 12885755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leptin--the key to obesity?].
    Drbalová K
    Cas Lek Cesk; 1998 Jun; 137(12):355-8. PubMed ID: 9721470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin mediates Clostridium difficile toxin A-induced enteritis in mice.
    Mykoniatis A; Anton PM; Wlk M; Wang CC; Ungsunan L; Blüher S; Venihaki M; Simeonidis S; Zacks J; Zhao D; Sougioultzis S; Karalis K; Mantzoros C; Pothoulakis C
    Gastroenterology; 2003 Mar; 124(3):683-91. PubMed ID: 12612907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of aberrant crypt foci in the colons of ob/ob and db/db mice: evidence that leptin is not a promoter.
    Ealey KN; Lu S; Archer MC
    Mol Carcinog; 2008 Sep; 47(9):667-77. PubMed ID: 18240295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice.
    Delporte ML; El Mkadem SA; Quisquater M; Brichard SM
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E446-53. PubMed ID: 15126241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
    van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H
    J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.
    Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clément K; Holvoet P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2691-8. PubMed ID: 17690315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
    Brun P; Castagliuolo I; Di Leo V; Buda A; Pinzani M; Palù G; Martines D
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G518-25. PubMed ID: 17023554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone abnormalities in adolescent leptin-deficient mice.
    Ealey KN; Fonseca D; Archer MC; Ward WE
    Regul Pept; 2006 Sep; 136(1-3):9-13. PubMed ID: 16764953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic effect of Rofecoxib in a murine venous thrombosis model.
    Nagai N; Hoylaerts MF; Gallacher DJ; Lu HR; Lijnen HR
    Thromb Res; 2008; 122(5):668-73. PubMed ID: 18571222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines and thrombosis.
    Schäfer K; Konstantinides S
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):864-71. PubMed ID: 21848866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between diencephalic thyroliberin and arterial blood pressure in agouti-yellow and ob/ob mice may be mediated by leptin.
    Burgueño AL; Landa MS; Schuman ML; Alvarez AL; Carabelli J; García SI; Pirola CJ
    Metabolism; 2007 Oct; 56(10):1439-43. PubMed ID: 17884458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of intestinal inflammation in double IL-10- and leptin-deficient mice.
    Siegmund B; Sennello JA; Lehr HA; Batra A; Fedke I; Zeitz M; Fantuzzi G
    J Leukoc Biol; 2004 Oct; 76(4):782-6. PubMed ID: 15240754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of leptin on the ventilatory responseto hyperoxia.
    Groeben H; Meier S; Brown RH; O'Donnell CP; Mitzner W; Tankersley CG
    Exp Lung Res; 2004; 30(7):559-70. PubMed ID: 15371092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice.
    Coenen KR; Gruen ML; Hasty AH
    J Nutr Biochem; 2007 Nov; 18(11):727-35. PubMed ID: 17418556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.